Inventor

BROWN GILES ALBERT

GB61 patents

⚠️ This page may combine multiple inventors who share the name “BROWN GILES ALBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HEPTARES THERAPEUTICS LTD

44 patents

US9670183B2Jun 6, 2017

Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD34 citations98

US10961225B2Mar 30, 2021

Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor

HEPTARES THERAPEUTICS LTD11 citations94

US10689368B2Jun 23, 2020

Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor

HEPTARES THERAPEUTICS LTD12 citations94

US10196380B2Feb 5, 2019

Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD20 citations94

US9926297B2Mar 27, 2018

Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD19 citations94

US9758506B2Sep 12, 2017

Muscarinic agonists

HEPTARES THERAPEUTICS LTD22 citations94

US10112923B2Oct 30, 2018

1,2,4-triazine-4-amine derivatives

HEPTARES THERAPEUTICS LTD20 citations93

US10030035B2Jul 24, 2018

Muscarinic receptor agonists

HEPTARES THERAPEUTICS LTD14 citations93

US9907805B2Mar 6, 2018

Muscarinic M1 receptor agonists

HEPTARES THERAPEUTICS LTD15 citations93

US9669013B2Jun 6, 2017

Bicyclic aza compounds as muscarinic M1 receptor agonists

HEPTARES THERAPEUTICS LTD14 citations93

US9573929B2Feb 21, 2017

Muscarinic M1 receptor agonists

HEPTARES THERAPEUTICS LTD12 citations93

US9266857B2Feb 23, 2016

Bicyclic AZA compounds as muscarinic M1 receptor agonists

HEPTARES THERAPEUTICS LTD23 citations93

US10385039B2Aug 20, 2019

Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists

HEPTARES THERAPEUTICS LTD13 citations92

US11773090B2Oct 3, 2023

Pharmaceutical compounds

HEPTARES THERAPEUTICS LTD6 citations86

US11352342B2Jun 7, 2022

Pharmaceutical compounds

HEPTARES THERAPEUTICS LTD9 citations86

US11324738B2May 10, 2022

Muscarinic agonists

HEPTARES THERAPEUTICS LTD9 citations86

US11319312B2May 3, 2022

Pharmaceutical compounds

HEPTARES THERAPEUTICS LTD10 citations86

US11254656B2Feb 22, 2022

Muscarinic agonists

HEPTARES THERAPEUTICS LTD10 citations86

US11208396B2Dec 28, 2021

Oxime compounds as agonists of the muscarinic M1 and/or M4 receptor

HEPTARES THERAPEUTICS LTD9 citations86

US11091456B2Aug 17, 2021

Muscarinic agonists

HEPTARES THERAPEUTICS LTD10 citations86

US11034704B2Jun 15, 2021

Muscarinic receptor agonists

HEPTARES THERAPEUTICS LTD10 citations86

US11014880B2May 25, 2021

Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD9 citations86

US10973832B2Apr 13, 2021

Muscarinic M1 receptor agonists

HEPTARES THERAPEUTICS LTD10 citations86

US10858352B2Dec 8, 2020

Pharmaceutical compounds

HEPTARES THERAPEUTICS LTD11 citations86

US10787447B2Sep 29, 2020

Pharmaceutical compounds

HEPTARES THERAPEUTICS LTD11 citations86

US10759751B2Sep 1, 2020

Substituted spirocyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD12 citations86

US10548884B2Feb 4, 2020

Muscarinic agonists

HEPTARES THERAPEUTICS LTD11 citations86

US10738029B2Aug 11, 2020

Muscarinic agonists

HEPTARES THERAPEUTICS LTD12 citations85

US10752610B2Aug 25, 2020

Pharmaceutical compounds

HEPTARES THERAPEUTICS LTD10 citations84

US10428088B2Oct 1, 2019

Muscarinic receptor agonists

HEPTARES THERAPEUTICS LTD11 citations84

US10413553B2Sep 17, 2019

Muscarinic M1 receptor agonists

HEPTARES THERAPEUTICS LTD11 citations84

US10351545B2Jul 16, 2019

Muscarinic agonists

HEPTARES THERAPEUTICS LTD10 citations84

US10329278B2Jun 25, 2019

Pharmaceutical compounds

HEPTARES THERAPEUTICS LTD13 citations84

US10259802B2Apr 16, 2019

Bicyclic aza compounds as muscarinic M1 receptor antagonists

HEPTARES THERAPEUTICS LTD9 citations84

US10259787B2Apr 16, 2019

Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD13 citations84

US10167272B2Jan 1, 2019

Muscarinic agonists

HEPTARES THERAPEUTICS LTD11 citations84

US10167284B2Jan 1, 2019

Spirocyclic compounds as agonists of the muscarinic M1 receptor and/or M4 receptor

HEPTARES THERAPEUTICS LTD12 citations84

US9975890B2May 22, 2018

Bicyclic AZA compounds as muscarinic M1 receptor antagonists

HEPTARES THERAPEUTICS LTD10 citations84

US11945801B2Apr 2, 2024

Bicyclic aza compounds as muscarinic M1 and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD3 citations75

US11834407B2Dec 5, 2023

Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists

HEPTARES THERAPEUTICS LTD5 citations75

US12024499B2Jul 2, 2024

Muscarinic agonists

HEPTARES THERAPEUTICS LTD2 citations72

US10988455B2Apr 27, 2021

1,2,4-triazine-4-amine derivatives

HEPTARES THERAPEUTICS LTD1 citations72

US9249130B2Feb 2, 2016

1,2,4-triazine-4-amine derivatives

HEPTARES THERAPEUTICS LTD3 citations72

US11793817B2Oct 24, 2023

Muscarinic M1 receptor agonists

HEPTARES THERAPEUTICS LTD0 citations63

NXERA PHARMA UK LTD

5 patents

US12291512B2May 6, 2025

Oxime compounds as agonists of the muscarinic M1 and/or M4 receptor

NXERA PHARMA UK LTD0 citations62

US12215099B2Feb 4, 2025

Quinolinone and benzoxazine derivatives as muscarinic M1 and/or M4 receptor agonists

NXERA PHARMA UK LTD0 citations62

US12202843B2Jan 21, 2025

Muscarinic receptor agonists

NXERA PHARMA UK LTD0 citations62

US12234227B2Feb 25, 2025

Pyrazole derivatives as H4 antagonist compounds

NXERA PHARMA UK LTD0 citations61

US12054472B2Aug 6, 2024

1,2,4-triazine-4-amine derivatives

NXERA PHARMA UK LTD0 citations61

CONGREVE MILES STUART

1 patent

US8809525B2Aug 19, 2014

1,2,4-triazine-4-amine derivatives

CONGREVE MILES STUART7 citations81

Showing the top 50 of 61 patents by PatentIndex Score.